IV Workshop: Programa Educacional sobre Cáncer de Ovario y BRCA

IV WORKSHOP: PROGRAMA EDUCACIONAL SOBRE CÁNCER DE OVARIO Y BRCA

Programa Educacional sobre cancer de ovario y BRCA

IV_Workshop_ProgramaEducacionalsobrecancerdeovarioyBRCA

Interactive clinical case

HRD in Ovarian Cancer: a biological perspective

HRD and PARPi: update from recent clinical trials and clinical perspective

In favor of PARPi as a monotherapy

In favor of platinum – based chemotherapy followed by PARPi as maintenance

In favor of surgery

In favor of systemic therapy

In favor of genetic testing driven by therapeutics:
BRCA first and sequential panel after

In favor of panel testing from upfront

Update of immunotherapy for BRCA – ovarian cancer and beyond

Rationale for designing clinical trials with PARP inhibitors in combination